Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susana Banerjee

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Expert Opinion on Pharmacotherapy|March 12, 2016
Olaparib for the treatment of epithelial ovarian cancerJennifer McLachlan, Susana Banerjee
Clinical Colorectal Cancer|July 16, 2010
Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questionsSusana Banerjee, David Cunningham
Expert Review of Anticancer Therapy|August 22, 2015
Pazopanib in ovarian cancerJennifer McLachlan, Susana Banerjee
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2012
Recent advances in systemic treatments for ovarian cancerSusana Banerjee, Martin Gore
Current Opinion in Oncology|May 15, 2012
Molecular targets and targeted therapeutics in endometrial cancerBritta Weigelt, Susana Banerjee
Cancer Treatment Reviews|June 4, 2018
Burnout in oncologists is a serious issue: What can we do about it?Krithika Murali, Susana Banerjee
Current Oncology Reports|September 5, 2012
Progression-free survival versus overall survival in ovarian cancer: where are we now?Susana Banerjee, Stan Kaye
The Lancet. Oncology|December 4, 2010
Management of small HER2-positive breast cancersSusana Banerjee, Ian E Smith
Nature Reviews. Clinical Oncology|February 29, 2012
Gynecological cancer: First-line bevacizumab for ovarian cancer--new standard of care?Susana Banerjee, Stan B Kaye
Breast (Edinburgh, Scotland)|November 17, 2009
The follow-up of women at high risk for breast cancer relapseIan E Smith, Susana Banerjee
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Expert Opinion on Pharmacotherapy|March 12, 2016
Olaparib for the treatment of epithelial ovarian cancerJennifer McLachlan, Susana Banerjee
Clinical Colorectal Cancer|July 16, 2010
Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questionsSusana Banerjee, David Cunningham
Expert Review of Anticancer Therapy|August 22, 2015
Pazopanib in ovarian cancerJennifer McLachlan, Susana Banerjee
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2012
Recent advances in systemic treatments for ovarian cancerSusana Banerjee, Martin Gore
Current Opinion in Oncology|May 15, 2012
Molecular targets and targeted therapeutics in endometrial cancerBritta Weigelt, Susana Banerjee
Cancer Treatment Reviews|June 4, 2018
Burnout in oncologists is a serious issue: What can we do about it?Krithika Murali, Susana Banerjee
Current Oncology Reports|September 5, 2012
Progression-free survival versus overall survival in ovarian cancer: where are we now?Susana Banerjee, Stan Kaye
The Lancet. Oncology|December 4, 2010
Management of small HER2-positive breast cancersSusana Banerjee, Ian E Smith
Nature Reviews. Clinical Oncology|February 29, 2012
Gynecological cancer: First-line bevacizumab for ovarian cancer--new standard of care?Susana Banerjee, Stan B Kaye
Breast (Edinburgh, Scotland)|November 17, 2009
The follow-up of women at high risk for breast cancer relapseIan E Smith, Susana Banerjee
Pageof 18